Recognition, Resuscitation, and Treatment of Postpartum Hemorrhage in the Intensive Care Unit

Author(s): Sophie Rooks, PharmD, MAA, Sarah Berman, PharmD, BCCCP, Holly Ryan, PharmD, BCEMP, DPLA

Contact Hours 1.00

CERP A 1.00

Pharmacology Hours 1.00

Expires Dec 01, 2029

Topics: Hematology/Oncology, Medication Management

Population: Adult

Role: APRN, Staff

Fees
Member: Free
NonMember: $10.00

Added to Collection

Activity Summary

Before you Begin

1. Reflect on the following question: What new knowledge or perspective do you hope to gain from this activity?

2. Review: Implicit Bias and its Impact on Patient Outcomes (License requirement for California)

Description

Obstetric hemorrhage is a leading cause of maternal morbidity and mortality and requires prompt recognition and coordinated management in critically ill patients. This activity provides an overview of current approaches to hemorrhage management, with a focus on pharmacologic treatment and transfusion-based resuscitation strategies used in critical care settings.

Objectives

  • Describe the pharmacologic therapies used in the management of obstetric hemorrhage, including uterotonics and tranexamic acid.
  • Identify patient-specific factors, contraindications, and monitoring considerations that guide pharmacologic treatment.
  • Describe the role of blood products and adjunctive therapies in the resuscitation of patients with severe obstetric hemorrhage.

Continuing Education Disclosure Statement

Criteria for Awarding Contact Hours

Learners must complete the entire activity and the associated evaluation AND read Implicit Bias impacts patient outcomes. No partial credit will be awarded.

Accreditation

American Association of Critical-Care Nurses is accredited as a provider of nursing continuing professional development by the American Nurses Credentialing Center's Commission on Accreditation.
Provider approved by the California Board of Registered Nursing, Provider number CEP 1036, for {contactHours} contact hours.

Disclosures

The Nurse Planner has determined that no individuals with the ability to control content of this activity have relevant relationships with ineligible companies.

Activities with pharmacotherapeutic credit are to assist the APRN in fulfilling their education requirements for licensure and certification renewals.

Refund Policy

Continuing Education Activities are nonrefundable.